Pitcairn’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,675
Closed -$511K 608
2025
Q3
$511K Hold
3,675
0.04% 343
2025
Q2
$495K Hold
3,675
0.03% 406
2025
Q1
$537K Hold
3,675
0.03% 412
2024
Q4
$506K Sell
3,675
-2,000
-35% -$293K 0.03% 431
2024
Q3
$874K Buy
5,675
+2,000
+54% +$303K 0.05% 295
2024
Q2
$536K Hold
3,675
0.03% 427
2024
Q1
$543K Sell
3,675
-247
-6% -$35.4K 0.04% 414
2023
Q4
$535K Hold
3,922
0.04% 382
2023
Q3
$505K Sell
3,922
-602
-13% -$79.9K 0.04% 355
2023
Q2
$600K Sell
4,524
-201
-4% -$26.5K 0.05% 304
2023
Q1
$612K Buy
4,725
+325
+7% +$42.5K 0.06% 294
2022
Q4
$598K Hold
4,400
0.06% 275
2022
Q3
$533K Hold
4,400
0.06% 277
2022
Q2
$564K Hold
4,400
0.06% 272
2022
Q1
$603K Hold
4,400
0.05% 306
2021
Q4
$620K Hold
4,400
0.04% 319
2021
Q3
$560K Hold
4,400
0.04% 311
2021
Q2
$554K Hold
4,400
0.04% 312
2021
Q1
$514K Buy
+4,400
New +$508K 0.04% 321

Other funds holding XLV

Pitcairn's XLV Position: Q4 2025 in Review

Pitcairn sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q4 2025, closing a stake of 3,675 shares — an estimated $511K sold.

Pitcairn first reported a position in XLV in Q1 2021 and held it in 19 quarters. The position peaked at $874K in Q3 2024. 1,832 funds tracked by Wall St. Rank hold XLV as of Q4 2025.

  • Pitcairn reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q4 2025 after selling out during the quarter.
  • Pitcairn sold 3,675 State Street Health Care Select Sector SPDR ETF shares in Q4 2025, an estimated $511K.
  • Pitcairn first reported a position in State Street Health Care Select Sector SPDR ETF in Q1 2021 and held it in 19 quarters.
  • Pitcairn's State Street Health Care Select Sector SPDR ETF position peaked at $874K in Q3 2024.
  • 1,832 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q4 2025.

Based on Pitcairn's 13F filing for Q4 2025.